Free practice quiz
BCNP Prep Course (BCNP): free quiz
10 questions from the program. See your score right away, then unlock the explanation of every answer.
- Question 1 of 10
In a licensed nuclear pharmacy, a pharmacist is verifying a 99mTc-sestamibi intravenous dose for a same-day myocardial perfusion study. The order is for 25 mCi IV once today. Which radionuclide production source best explains the routine on-site availability of 99mTc from a parent-daughter system used for daily elution and dispensing?
Why B is correct
99mTc used for routine compounding is commonly obtained from a 99Mo/99mTc generator. The parent-daughter relationship supports repeated elutions, making workflow efficient for daily nuclear pharmacy dispensing. This production source directly affects availability and scheduling.
NOTICE: whether the ordered kit requires generator-derived 99mTc and whether eluate timing supports the prescribed activity. SAY: confirm dose timing with the technologist if activity may be borderline. MONITOR: generator elution yield, breakthrough, and calibration each use day. HOLD/CLARIFY/ESCALATE: hold release if QC or assay results are out of specification.
Why the other options are incorrect
C: Tempting because reactors produce many medical radionuclides. It is eliminated because the question asks about repeated on-site elution from a parent-daughter system, which describes a generator, not a sealed reactor source. D: Tempting because cyclotrons are common for PET radionuclides. It is eliminated because direct cyclotron production does not describe routine generator elution of 99mTc. A: Tempting because supply chain language can sound like a source category. It is eliminated because clinical 99mTc availability depends on radioactive decay of a parent, not a stable isotope source.
NOTICE: the production method named in the order workflow. SAY: explain any source-related delay or limitation to the care team. MONITOR: source-specific expiration, impurity controls, and daily operational readiness. HOLD/CLARIFY/ESCALATE: escalate if source selection conflicts with package insert, QC results, or procurement records.
- Question 2 of 10
An order is delayed after the radiopharmaceutical dose has already been prepared and calibrated. The pharmacist needs to determine whether recalibration or activity adjustment is needed before release. Which concept is most directly relevant?
A. This is correct because physical half-life drives calibration timing, making it the key property when a dose is delayed after calibration.
B. This is incorrect because the selected source node does not connect patient consent format with activity decay or calibration timing.
C. This is incorrect because package branding does not represent the radionuclide physical behavior emphasized in the source pack.
D. This is incorrect because staffing may affect workflow, but it does not determine radioactive decay or calibration timing in the supplied topic.
- Question 3 of 10
A pharmacist is asked to review whether a radiopharmaceutical is appropriate for the intended imaging procedure. The only source-pack clue provided is that photon energy affects imaging suitability. Which action is most appropriate?
A. Correct. The node states that photon energy affects imaging suitability and that detection principles support product selection, making emission energy and detection approach relevant.
B. Incorrect. Inventory management is part of the broader blueprint, but the selected node does not support inventory quantity as the only determinant of imaging suitability.
C. Incorrect. Storage is a procurement and storage issue, but the node supports evaluating physical emission and detection properties for selection.
D. Incorrect. The node states that energy influences shielding choices and supports a relationship between energy, detection, and product selection.
- Question 4 of 10
A trainee says that once a product is radioactive, its chemical form no longer matters. Which correction is best supported by the source pack?
A. Correct. The node explicitly states that chemical form affects target localization, and the parent section links chemical form with biologic behavior.
B. Incorrect. The selected topic is radiochemical forms and purity within radionuclide science, so it applies to radiopharmaceuticals.
C. Incorrect. Shipping labels are not the main issue; the node emphasizes localization, purity, stability, and biodistribution.
D. Incorrect. The parent section states that chemical form and biologic behavior determine localization and altered biodistribution.
- Question 5 of 10
A patient factor is suspected to have affected localization of a radiopharmaceutical. Which statement best reflects the BCNP-relevant principle for the pharmacist?
A. Correct. The source pack states that patient factors alter expected localization, and the blueprint connects this topic to pharmacokinetics and altered biodistribution.
B. Incorrect. Correct labeling does not make patient factors irrelevant; the node specifically includes patient factors as causes of altered localization.
C. Incorrect. Receipt, labeling, storage, and shipping are separate blueprint areas, while this node concerns biologic behavior, PK, and altered biodistribution.
D. Incorrect. The source pack does not support waiting for repeated imaging with a different radionuclide before considering patient-related causes.
- Question 6 of 10
A BCNP candidate is studying kit formulation. Which set of components should the candidate specifically recognize as important according to the selected node?
A. Correct. The high-yield bullets identify buffers, reductants, stabilizers, and excipients as components that matter for kit formulation.
B. Incorrect. These are instrumentation examples in the broader blueprint, not kit formulation components from this node.
C. Incorrect. Patient education is a patient care area, not the kit component focus of this topic.
D. Incorrect. Receipt, labeling, storage, shipping, and inventory are blueprint areas, but the selected node focuses on vial contents, component function, and excipients.
- Question 7 of 10
A component is received with an intact package and correct storage conditions, but no quality documentation is available. What is the most appropriate next step before preparation?
A. Packaging condition alone does not satisfy the requirement to assess identity and quality documentation.
B. This is correct because the source requires assessment of quality documentation and confirmation of suitability before use.
C. The source does not permit bypassing documentation review based on patient risk.
D. Recording unavailable documentation after preparation does not meet the expectation to confirm suitability before use.
- Question 8 of 10
At 08:15, a nuclear pharmacist receives a package containing technetium Tc 99m medronate with shipping papers listing one vial for intravenous use, to be prepared for a single scheduled dose today. During the required receipt survey, the outer package is intact, but the wipe test from the package surface exceeds the facility action level for removable contamination. The exposure rate at the package surface is within expected limits and the shipping papers match the contents. What is the most appropriate pharmacist action?
Why B is correct
A wipe test above the removable contamination limit is a receipt abnormality that requires the pharmacist to hold the package, prevent further spread, document the event, and escalate according to radiation safety and carrier/licensee procedures. Matching paperwork and acceptable external dose rate do not override contamination findings. The PK/PD issue is irrelevant here; release depends on package integrity and radiation safety compliance.
Pharmacist Action: NOTICE the failed contamination survey; SAY the package is on hold pending radiation-safety handling; MONITOR contamination survey results and area status immediately; HOLD/CLARIFY/ESCALATE when wipe results exceed the action limit.
Why D is incorrect
This is tempting because the exposure rate and paperwork are acceptable. The eliminating fact is that removable contamination failure alone is sufficient to withhold release and trigger response procedures.
Pharmacist Action: NOTICE that one acceptable survey parameter does not cancel another failed parameter; SAY the package cannot be used yet; MONITOR both exposure and contamination checks on receipt; HOLD when any required survey fails.
Why A is incorrect
This is tempting because repeating a test may seem practical. The eliminating fact is that a contaminated package should be controlled immediately, not placed into routine storage or delayed for later reassessment.
Pharmacist Action: NOTICE delay increases spread risk; SAY the package must be segregated now; MONITOR the controlled area and follow-up survey timing per procedure; ESCALATE immediately rather than waiting until end of day.
Why C is incorrect
This is tempting because confirming the contamination source seems useful. The eliminating fact is that opening a suspect contaminated package in a routine dispensing area may spread contamination and is not the safest initial pharmacist action.
Pharmacist Action: NOTICE the risk of contamination spread during opening; SAY the package will be managed under contamination-control procedure; MONITOR containment and personnel exposure during follow-up handling; HOLD and use the designated controlled process before opening.
- Question 9 of 10
A facility is writing a storage policy for radioactive materials. The policy writer notes that state and institutional requirements may not be identical across sites. Which statement best reflects the source pack?
A. This is correct because the node explicitly states that local requirements may vary.
B. This is incorrect because the source pack directly acknowledges local variation rather than a single identical implementation at all sites.
C. This is incorrect because the node is specifically about storage conditions and security, not only patient counseling.
D. This is incorrect because local variation does not negate the stated storage principles of controlling access, shielding, and preventing unauthorized removal.
- Question 10 of 10
In the context of BCNP procurement and inventory operations, why is expiration labeling especially important for radiopharmaceuticals?
A. This is correct because the selected topic directly ties expiration controls to prevention of wrong-time dispensing within receipt, labeling, and storage operations.
B. This is incorrect because the node is about operational labeling and expiration controls, not diagnosis.
C. This is incorrect because labeling is one component of receipt, labeling, and storage controls; it does not replace those procedures.
D. This is incorrect because the source emphasizes operational identification and timing safety, not billing-only functions.
See why each answer is right or wrong
Enter your email to unlock the explanation of every question, free.